– Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments –– Landmark research project is 100x larger than existing efforts –– Data will be generated from thousands of patients across multiple cancers.
– Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments –
–. | June 1, 2023
Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments Landmark research project
MOSAIC aims to be the world's largest spatial omics project in cancer research. Owkin is the sponsor of this $50 million research initiative that combines its AI expertise with technological know-how from NanoString and the clinical expertise of 5 world class cancer research centers across Europe and the USA.